Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional aminoacids

Archiv der Pharmazie

Volumn 344, Issue 8, 2011, Pages 505-513

  Csuk, René ^a   Schwarz, Stefan ^a   Kluge, Ralph ^a   Ströhl, Dieter ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antitumor activity; Apoptosis; Glycyrrhetinic acid; Mouse embryonic fibroblasts

Indexed keywords

ACRIDINE ORANGE; AMINO ACID; ETHIDIUM BROMIDE; GLYCYRRHETINIC ACID; GLYCYRRHETINIC ACID DERIVATIVE; METHYL 3BETA 3 (BOC LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (BOC LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (BOC O BENZYL LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (BOC O BENZYL LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (BOC O METHYL LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (BOC O METHYL LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE HYDROCHLORIDE; METHYL 3BETA 3 (LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE HYDROCHLORIDE; METHYL 3BETA 3 (O BENZYL LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (O BENZYL LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (O METHYL LEVO ASPARAGYL) 11 OXO OLEAN 12 EN 30 OATE; METHYL 3BETA 3 (O METHYL LEVO GLUTAMYL) 11 OXO OLEAN 12 EN 30 OATE; SULFORHODAMINE B; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG CYTOTOXICITY; DRUG SELECTIVITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR CELL;

AMINO ACIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; GLYCYRRHETINIC ACID; HUMANS; NEOPLASMS;

EID: 80051488965     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201100030     Document Type: Article

References (14)

1. H. Hibasami, H. Iwase, K. Yoshioka, H. Takahashi, Int. J. Mol. Med. 2006, 17, 215-219.
2. D. Liu, D. Song, G. Guo, R. Wang, J. Lv, Y. Jing, L. Zhao, Bioorg. Med. Chem. 2007, 15, 5432-5439.
3. C. S. Lee, Y. J. Kim, M. S. Lee, E. S. Han, S. J. Lee, Life Sci. 2008, 83, 481-489.
4. J. Tatsuzaki, M. Taniguchi, K. F. Bastow, K. Nakagawa-Goto, S. L. Morris-Natschke, H. Itokawa, K. Baba, K.-H. Lee, Bioorg. Med. Chem. 2007, 15, 6193-6199.
5. H. Abe, N. Ohya, K. F. Yamamoto, T. Shibuya, S. Arichi, S. Odashima, Eur. J. Cancer Clin. Oncol. 1987, 23, 1549-1553.
6. S. Schwarz, R. Csuk, Bioorg. Med. Chem. 2010, 18, 7458-7474.
7. L. A. Baltina, Curr. Med. Chem. 2003, 10, 155-171.
8. D. R. Lauren, D. J. Jensen, J. A. Douglas, J. M. Follet, Phytochem. Anal. 2001, 12, 332-333.
9. C. Gauthier, J. Legault, K. Girard-Lalancette, V. Mshvildadze, A. Pichette, Bioorg. Med. Chem. 2009, 17, 2002-2008.
10. R. Csuk, A. Barthel, S. Schwarz, H. Kommera, R. Paschke, Bioorg. Med. Chem. 2010, 18, 2549-2558.
11. G. Chadalapaka, I. Jutooru, A. McAlees, T. Stefanac, S. Safe, Bioorg. Med. Chem. Lett. 2008, 18, 2633-2639.
12. H. Kommera, G. N. KaluÄ'eroviÄ, J. Kalbitz, R. Paschke, Arch. Pharm. Chem. Life Sci. 2010, 343, 449-457.
13. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney, M. R. Boyd, J. Natl. Cancer Inst. 1990, 82, 1107-1112.
14. D. C. Gowda, K. Abiraj, P. Augustine, Lett. Peptide Sci. 2002, 9, 43-47.